Mirae Asset Global Etfs Holdings Ltd. Beam Therapeutics Inc. Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $39.6 Billion
- Q2 2024
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Beam Therapeutics Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 174,180 shares of BEAM stock, worth $5.29 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
174,180Holding current value
$5.29 Million% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding BEAM
# of Institutions
230Shares Held
73.3MCall Options Held
283KPut Options Held
233K-
Farallon Capital Management LLC San Francisco, CA7.91MShares$240 Million0.9% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.9MShares$240 Million0.0% of portfolio
-
Black Rock Inc. New York, NY7.63MShares$232 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl6.53MShares$198 Million1.52% of portfolio
-
Arch Venture Management, LLC Chicago, IL5.44MShares$165 Million74.72% of portfolio
About Beam Therapeutics Inc.
- Ticker BEAM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 70,354,600
- Market Cap $2.14B
- Description
- Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen ...